Invictus Secures Supply
Agreement with British Columbia Liquor Distribution
Branch
VANCOUVER, BC, Canada -- July 11, 2018 -- InvestorsHub NewsWire
--
INVICTUS MD STRATEGIES CORP. ("Invictus" or the
"Company") (TSXV: GENE; OTC: IVITF; FRA:
8IS1) is pleased to announce that it has signed a
Memorandum of Understanding ("
MOU") with the BC
Liquor Distribution Branch
("LDB") to
supply the province with a selection of premium cannabis products
for the upcoming recreational marketplace. Invictus' portfolio
includes award-winning strains, supplied by our wholly-owned
subsidiary, Acreage Pharms Ltd.
("Acreage
Pharms"), located in Alberta.
“As a company with operations in BC, Invictus is immensely proud to
have been selected to provide the LDB with quality cannabis
products ahead of legalization on October 17, 2018,” said Dan
Kriznic, Chairman and CEO of Invictus. “We are looking forward to a
partnership that will work to achieve our mutual objectives of
building a safer marketplace for cannabis, while spurring economic
activity here at home.”
Beyond supply agreements, Invictus is working to develop and
implement a strategic patient acquisition program aimed at winning
market share for medical cannabis sales, in addition to its
ambitions retail plan that involves establishing dispensaries
across Western Canada. At the same time, Invictus is taking
measured steps to expand our cultivation space and strain profile,
as demand in the adult recreational market continues to grow.
The MOU with BC’s LDB is the Company’s first provincial supply
agreement to service the adult-use market and falls in line with
our multi-faceted sales and distribution strategy.
For more information, please visit
www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman and CEO
Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(647) 828-9655
About Invictus
Invictus owns and operates two cannabis production facilities, both
with sales licenses, under the ACMPR in Canada, with the vision of
producing a variety of high quality and low-cost cannabis products
to the global market, as regulations permit. The Company’s wholly
owned subsidiary, Acreage Pharms Ltd. (“
Acreage
Pharms”), is located in West-Central Alberta. The
Company’s 50% owned AB Laboratories Inc. (“
AB
Labs”), is located in Hamilton, Ontario. AB Ventures Inc.
(“
AB Ventures”) owns 100 acres of land near
INVICTUS The Cannabis Company Hamilton, Ontario, to be used for
future cannabis cultivation. Recently, the Company announced that
it has entered into a binding letter of intent for an option to
acquire an applicant (the “
OptionCo”) under the
ACMPR. Combined, the Company expects to have approximately 262,000
and 846,000 square feet of cannabis production capacity by the end
of 2018 and 2019, respectively.
Gene Simmons, music legend and media mogul, conveys the vision of
Invictus as the Chief Evangelist Officer.
The Company’s wholly owned subsidiary, Poda Technologies Ltd.
(“
Poda”), has developed the world’s first
zero-cleaning vaporizer system. Poda’s fully biodegradable pods are
self-contained, and do not contaminate the vaporizer with odor,
flavor or residue.
Finally, the Company’s 82.5% owned Future Harvest Development Ltd.
(“
Future Harvest”) is a high-quality Fertilizer
and Nutrients manufacturer, based in Kelowna, British Columbia.
Future Harvest has been in operation for over 20 years under the
brand Plant Life Products and Holland Secret.
Invictus’ Canadian Production Footprint:
Cautionary Note Regarding Forward-Looking Statements: This release
includes certain statements and information that may constitute
forward-looking information within the meaning of applicable
Canadian securities laws or forward-looking statements within the
meaning of the United States Private Securities Litigation Reform
Act of 1995. All statements in this news release, other than
statements of historical facts, including statements regarding
future estimates, plans, objectives, timing, assumptions or
expectations of future performance, including the expected use of
the proceeds from the Company’s option and warrant exercises and
the potential production capacity of OptionCo, AB Labs, AB Ventures
and Acreage Pharms, are forward-looking statements and contain
forward-looking information. Generally, forward-looking statements
and information can be identified by the use of forward-looking
terminology such as “intends” or “anticipates”, or variations of
such words and phrases or statements that certain actions, events
or results “may”, “could”, “should” or “would” occur.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that there will be no material change in the Company’s
business or market conditions that will require the Company to
alter its current anticipated use of the proceeds from the option
and warrant exercises that OptionCo, AB Labs, AB Ventures and
Acreage Pharms will be successful in reaching their potential
production capacity, OptionCo, AB Labs, AB Ventures and Acreage
Pharms’ production facilities will be completed as anticipated,
regulatory approval will be granted as anticipated, OptionCo, AB
Labs, AB Ventures and Acreage Pharms will reach full production
capacity on the timeline anticipated by the Company,. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forwardlooking statements or forward-looking information. Important
factors that may cause actual results to vary, include, without
limitation, there will be a material change in the Company’s
business or market conditions that will require the Company to
alter its current anticipated use of the proceeds from the option
and warrant exercises OptionCo, AB Labs, AB Ventures and Acreage
Pharms will not be successful in reaching its potential production
capacity, OptionCo, AB Labs, AB Ventures and Acreage Pharms
production facilities will not be completed as anticipated,
construction delays, regulatory approval will not be granted as
anticipated and therefore, the anticipated timing of OptionCo, AB
Labs, AB Ventures and Acreage Pharms reaching full production
capacity will be delayed. Although management of the Company has
attempted to identify important factors that could cause actual
results to differ materially from those contained in forwardlooking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
out-look that are incorporated by reference herein, except in
accordance with applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Sep 2023 to Sep 2024